References
- 2007 ESH‐ESC Guidelines. Blood Press 2007; 16: 135–232
- Waeber B., Brunner H. R. Joint National Committee in the US (JNC‐VI); World Health Organization–International Society of Hypertension (WHO‐ISH) The multifactorial nature of hypertension: The greatest challenge for its treatment?. J Hypertens 2001; 19(Suppl)S9–S16
- Elliott W. J. What factors contribute to the inadequate control of elevated blood pressure?. J Clin Hypertens (Greenwich) 2008; 10(Suppl 1)20–26
- Waeber B. Fixed low‐dose combination therapy for hypertension. Curr Hypertens Rep 2002; 4: 298–306
- Ruzicka M., Leenen F. H. Monotherapy versus combination therapy as first line treatment of uncomplicated arterial hypertension. Drugs 2001; 61: 943–954
- Rosenthal T., Gavras I. Fixed‐drug combinations as first‐line treatment for hypertension. Prog Cardiovasc Dis 2006; 48: 416–425
- Ruilope L. M., Burnier M., Muszbek N., Brown R. E., Keskinaslan A., Ferber P., et al. Public health value of fixed‐dose combinations in hypertension. Blood Press 2008; 17(Suppl 1)4–13
- Tuomilehto J., Tykarski A., Baumgart P., Reimund B., le Breton S., Ferber P. Combination therapy with valsartan/hydrochlorothiazide at doses up to 320/25 mg improves blood pressure levels in patients with hypertension inadequately controlled by valsartan 320 mg monotherapy. Blood Press 2008; 17(Suppl 1)14–22
- Schumacher H., Mancia G. The safety profile of telmisartan as monotherapy or combined with hydrochlorothiazide: A retrospective analysis of 50 studies. Blood Press 2008; 17(Suppl 1)31–39
- Kjeldsen S. E., Jamerson K. A., Bakris G. L., Pitt B., Bahlöf B., Velazques E. J., , for the ACCOMPLISH Investigators, et al. Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: The ACCOMPLISH Study. Blood Press 2008; 17: 7–17
- Ueng K‐C., Lin L‐C., Voon W‐C., Lin M‐C., Liu Y‐B., Su H‐M., et al. An eight week, multicenter, randomized, double‐blind study to evaluate the efficacy and tolerability of fixed‐dose amlodipine/benazepril combination with amlodipine as first‐line therapy in Chinese patients with mild to moderate hypertension. Blood Press 2008; 17(Suppl 1)23–30
- Bangalore S., Kamalakkannan G., Parkar S., Messerli F. H. Fixed‐dose combinations improve medication compliance: A meta‐analysis. Am J Med 2007; 120: 713–719
- Kjeldsen S. E., Oparil S., Narkiewicz K., Hedner T. A stunning day in hypertension research – Results on ONTARGET, ACCOMPLISH and HYVET. Blood Press 2008; 17: 68–69